These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9700998)

  • 1. Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hypertensive patients treated with cilnidipine or nifedipine retard.
    Minami J; Ishimitsu T; Kawano Y; Numabe A; Matsuoka H
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):331-6. PubMed ID: 9700998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients.
    Minami J; Ishimitsu T; Kawano Y; Matsuoka H
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):572-6. PubMed ID: 9673431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.
    Minami J; Kawano Y; Makino Y; Matsuoka H; Takishita S
    Br J Clin Pharmacol; 2000 Dec; 50(6):615-20. PubMed ID: 11136301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients.
    Minami J; Ishimitsu T; Higashi T; Numabe A; Matsuoka H
    Hypertens Res; 1998 Sep; 21(3):215-9. PubMed ID: 9786607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension.
    Minami J; Numabe A; Andoh N; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Br J Clin Pharmacol; 2004 May; 57(5):632-9. PubMed ID: 15089817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there any difference between intermediate-acting and long-acting calcium antagonists in diurnal blood pressure and autonomic nervous activity in hypertensive coronary artery disease patients?
    Hoshide S; Kario K; Mitsuhashi T; Ikeda U; Shimada K
    Hypertens Res; 2000 Jan; 23(1):7-14. PubMed ID: 10737129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients.
    Kitahara Y; Saito F; Akao M; Fujita H; Takahashi A; Taguchi H; Hino T; Otsuka Y; Kushiro T; Kanmatsuse K
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):68-73. PubMed ID: 14668570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
    Kawano Y; Makino Y; Okuda N; Takishita S; Omae T
    Blood Press Monit; 2000 Jun; 5(3):181-5. PubMed ID: 10915232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of white coat effect by cilnidipine in essential hypertension.
    Morimoto S; Takeda K; Oguni A; Kido H; Harada S; Moriguchi J; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Am J Hypertens; 2001 Oct; 14(10):1053-7. PubMed ID: 11710785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure monitoring in patients with essential hypertension treated with a new calcium antagonist, cilnidipine.
    Tominaga M; Ohya Y; Tsukashima A; Kobayashi K; Takata Y; Koga T; Yamashita Y; Fujishima Y; Abe I; Fujishima M
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):43-8. PubMed ID: 9140677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T; Shigematsu M
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
    Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
    Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.
    Kario K; Ando S; Kido H; Nariyama J; Takiuchi S; Yagi T; Shimizu T; Eguchi K; Ohno M; Kinoshita O; Yamada T
    J Clin Hypertens (Greenwich); 2013 Feb; 15(2):133-42. PubMed ID: 23339732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting lacidipine versus short-acting nifedipine in the treatment of asymptomatic acute blood pressure increase.
    Sánchez M; Sobrino J; Ribera L; Adrián MJ; Torres M; Coca A
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):479-84. PubMed ID: 10069685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
    Takei K; Araki N; Ohkubo T; Tamura N; Yamamoto T; Furuya D; Yanagisawa CT; Shimazu K
    Intern Med; 2009; 48(16):1357-61. PubMed ID: 19687579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
    Hoshide S; Kario K; Ishikawa J; Eguchi K; Shimada K
    Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
    Kanaoka T; Tamura K; Wakui H; Ohsawa M; Azushima K; Uneda K; Kobayashi R; Fujikawa T; Tsurumi-Ikeya Y; Maeda A; Yanagi M; Toya Y; Umemura S
    Int J Mol Sci; 2013 Aug; 14(8):16866-81. PubMed ID: 23959116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive activity of a new calcium channel blocker LF 2.0254, in spontaneously hypertensive rats: a comparison with nifedipine and nicardipine.
    Pruneau D; Brown NL
    Arch Int Pharmacodyn Ther; 1988; 295():109-24. PubMed ID: 2977540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension.
    Kishi T; Hirooka Y; Konno S; Sunagawa K
    Clin Exp Hypertens; 2009 May; 31(3):241-9. PubMed ID: 19387900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.